lymphocytic leukemia


Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
Related to lymphocytic leukemia: acute lymphocytic leukemia

lymphocytic leukemia

[¦lim·fə¦sid·ik lü′kē·mē·ə]
(medicine)
A type of leukemia in which lymphocytic cells predominate.
References in periodicals archive ?
It is FDA-approved in six distinct patient populations: chronic lymphocytic leukemia, small lymphocytic lymphoma, WaldenstrAaAaAeA m's macroglobulinemi along with previously-treated mantle cell lymphoma, previously-treated marginal zone lymphoma and previously-treated chronic graft-versus-host-disease (cGVHD).
Pipeline Products for Refractory Chronic Lymphocytic Leukemia (CLL) - Overview 9
Session Title: Poster Discussion Session, Hematologic MalignanciesLymphoma and Chronic Lymphocytic Leukemia
Patients with chronic lymphocytic leukemia (CLL), the most common leukemia in the Western world, exhibit heterogeneous clinical courses and survival rates;[sup][1] some patients have an indolent disease and do not require treatment whereas others have an aggressive disease, requiring treatment at initial presentation.
KEY WORDS: Chronic lymphocytic leukemia (CLL), Chemotherapy.
Chronic lymphocytic leukemia is a blood cancer characterized by neoplastic transformation and excess propagation of lymphocytes, a type of white blood cell, in the bone marrow.
The report provides comprehensive information on the therapeutics under development for Chronic Lymphocytic Leukemia (CLL), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
Biopharmaceutical company AbbVie (NYSE:ABBV) revealed on Friday that it has received US Food and Drug Administration (FDA) approval for IMBRUVICA (ibrutinib) for the first-line treatment for patients with chronic lymphocytic leukemia (CLL).
High incidence of monoclonal proteins in the serum and urine of chronic lymphocytic leukemia patients.
Chronic lymphocytic leukemia is the most common leukemia in the Western world, accounting for up to 30% of all adult leukemias, (5) and is characterized by proliferation of clonal mature B lymphocytes in peripheral blood, bone marrow, and lymphoid tissues.
A snapshot of the global therapeutic scenario for Refractory Chronic Lymphocytic Leukemia (CLL).
Key Words: Chronic lymphocytic leukemia (CLL), Autoimmune Hemolytic anemia (AIHA), Immune Thrombocytopenia (ITP).

Full browser ?